| Product Name |
Dabigatran Inhouse Impurity 19 / Dabigatran Carboxamide Ethyl Ester
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Heterocycles, Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines |
| CAS No |
1422435-41-3 |
| Catalog Number |
GS.01.DAB.49 |
| Chemical Name/Synonyms |
Ethyl 3-(2-(((4-carbamoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate ; ?-Alanine, N-[[2-[[[4-(aminocarbonyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester ; N-[[2-[[[4-(Aminocarbonyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-?-alanine ethyl ester |
| Molecular Weight |
500.55 |
| Molecular Formula |
C27H28N6O4 |
| Purity |
NLT 95 % |
| Appearance |
White to Off-White Solid |
| Solubility |
DMSO, Methanol |
| Applications |
Used to Prevent strokes and dangerous blood clots in patients diagnosed with non-valvular atrial fibrillation. |
| Inventory Status |
QC Pending
|
